Literature DB >> 18716131

Tumor necrosis factor SNP haplotypes are associated with iron deficiency anemia in West African children.

Sarah H Atkinson1, Kirk A Rockett, Gareth Morgan, Philip A Bejon, Giorgio Sirugo, Maria A O'Connell, Neil Hanchard, Dominic P Kwiatkowski, Andrew M Prentice.   

Abstract

Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are significantly raised in malaria infection and TNF-alpha is thought to inhibit intestinal iron absorption and macrophage iron release. This study investigated putative functional single nucleotide polymorphisms (SNPs) and haplotypes across the major histocompatibility complex (MHC) class III region, including TNF and its immediate neighbors nuclear factor of kappa light polypeptide gene enhancer in B cells (lkappaBL), inhibitor-like 1 and lymphotoxin alpha (LTA), in relation to nutritional iron status and anemia, in a cohort of 780 children across a malaria season. The prevalence of iron deficiency anemia (IDA) increased over the malaria season (P < .001). The TNF(-308) AA genotype was associated with an increased risk of iron deficiency (adjusted OR 8.1; P = .001) and IDA (adjusted OR 5.1; P = .01) at the end of the malaria season. No genotypes were associated with IDA before the malaria season. Thus, TNF appears to be a risk factor for iron deficiency and IDA in children in a malaria-endemic environment and this is likely to be due to a TNF-alpha-induced block in iron absorption.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18716131      PMCID: PMC2581977          DOI: 10.1182/blood-2008-06-162008

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  51 in total

1.  A new statistical method for haplotype reconstruction from population data.

Authors:  M Stephens; N J Smith; P Donnelly
Journal:  Am J Hum Genet       Date:  2001-03-09       Impact factor: 11.025

Review 2.  Single-nucleotide polymorphism analysis by MALDI-TOF mass spectrometry.

Authors:  T J Griffin; L M Smith
Journal:  Trends Biotechnol       Date:  2000-02       Impact factor: 19.536

3.  Plasma interleukin-10:Tumor necrosis factor (TNF)-alpha ratio is associated with TNF promoter variants and predicts malarial complications.

Authors:  J May; B Lell; A J Luty; C G Meyer; P G Kremsner
Journal:  J Infect Dis       Date:  2000-10-09       Impact factor: 5.226

4.  Tumor necrosis factor-alpha promoter variant 2 (TNF2) is associated with pre-term delivery, infant mortality, and malaria morbidity in western Kenya: Asembo Bay Cohort Project IX.

Authors:  M Aidoo; P D McElroy; M S Kolczak; D J Terlouw; F O ter Kuile; B Nahlen; A A Lal; V Udhayakumar
Journal:  Genet Epidemiol       Date:  2001-11       Impact factor: 2.135

5.  Characterization of a novel gene in the human major histocompatibility complex that encodes a potential new member of the I kappa B family of proteins.

Authors:  M R Albertella; R D Campbell
Journal:  Hum Mol Genet       Date:  1994-05       Impact factor: 6.150

6.  Relationship between TNF-alpha and iron metabolism in differentiating human monocytic THP-1 cells.

Authors:  A Scaccabarozzi; P Arosio; G Weiss; L Valenti; P Dongiovanni; A L Fracanzani; M Mattioli; S Levi; G Fiorelli; S Fargion
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

7.  Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism.

Authors:  W Kaluza; E Reuss; S Grossmann; R Hug; R E Schopf; P R Galle; E Maerker-Hermann; T Hoehler
Journal:  J Invest Dermatol       Date:  2000-06       Impact factor: 8.551

8.  Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis.

Authors:  S Fargion; L Valenti; P Dongiovanni; A Scaccabarozzi; A L Fracanzani; E Taioli; M Mattioli; M Sampietro; G Fiorelli
Journal:  Blood       Date:  2001-06-15       Impact factor: 22.113

9.  Direct evidence for involvement of NF-kappaB in transcriptional activation of tumor necrosis factor by a spirochetal lipoprotein.

Authors:  I A Udalova; V Vidal; I G Scragg; D Kwiatkowski
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

10.  Implications of inter-population linkage disequilibrium patterns on the approach to a disease association study in the human MHC class III.

Authors:  Neil Hanchard; Mahamadou Diakite; Oliver Koch; Brendan Keating; Margaret Pinder; Muminatou Jallow; Fatou Sisay-Joof; Anastasia Nijnik; Jonathan Wilson; Irina Udalova; Dominic Kwiatkowski; Kirk Rockett
Journal:  Immunogenetics       Date:  2006-04-28       Impact factor: 2.846

View more
  17 in total

Review 1.  Iron homeostasis and the inflammatory response.

Authors:  Marianne Wessling-Resnick
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

2.  Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 hemochromatosis and iron overload screening (HEIRS) study participants.

Authors:  Ronald T Acton; James C Barton; Catherine Leiendecker-Foster; Christopher Zaun; Christine E McLaren; John H Eckfeldt
Journal:  Blood Cells Mol Dis       Date:  2010-02-23       Impact factor: 3.039

Review 3.  Anemia of inflammation.

Authors:  Guenter Weiss; Tomas Ganz; Lawrence T Goodnough
Journal:  Blood       Date:  2018-11-06       Impact factor: 22.113

4.  Association of genetic variants with response to iron supplements in pregnancy.

Authors:  Rekha Athiyarath; Kalaiselvi Shaktivel; Vinod Abraham; Daisy Singh; Joseph Dian Bondu; Aaron Chapla; Biju George; Alok Srivastava; Eunice Sindhuvi Edison
Journal:  Genes Nutr       Date:  2015-05-30       Impact factor: 5.523

Review 5.  HLA and infectious diseases.

Authors:  Jenefer M Blackwell; Sarra E Jamieson; David Burgner
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

6.  Association between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea.

Authors:  Suk Pyo Shin; Nam Keun Kim; Ju Hwan Kim; Ju Ho Lee; Jung Oh Kim; Sung Hwan Cho; Hana Park; Mi Na Kim; Kyu Sung Rim; Seong Gyu Hwang
Journal:  World J Gastroenterol       Date:  2015-12-14       Impact factor: 5.742

7.  Randomised controlled trial of weekly chloroquine to re-establish normal erythron iron flux and haemoglobin recovery in postmalarial anaemia.

Authors:  Sharon E Cox; Chidi V Nweneka; Conor P Doherty; Anthony J Fulford; Sophie E Moore; Andrew M Prentice
Journal:  BMJ Open       Date:  2013-07-04       Impact factor: 2.692

Review 8.  Genetic polymorphisms linked to susceptibility to malaria.

Authors:  Adel Driss; Jacqueline M Hibbert; Nana O Wilson; Shareen A Iqbal; Thomas V Adamkiewicz; Jonathan K Stiles
Journal:  Malar J       Date:  2011-09-19       Impact factor: 2.979

9.  Combinatorial effects of malaria season, iron deficiency, and inflammation determine plasma hepcidin concentration in African children.

Authors:  Sarah H Atkinson; Andrew E Armitage; Shivani Khandwala; Tabitha W Mwangi; Sophie Uyoga; Philip A Bejon; Thomas N Williams; Andrew M Prentice; Hal Drakesmith
Journal:  Blood       Date:  2014-03-04       Impact factor: 22.113

10.  Implications of malaria on iron deficiency control strategies.

Authors:  Natasha Spottiswoode; Michal Fried; Hal Drakesmith; Patrick E Duffy
Journal:  Adv Nutr       Date:  2012-07-01       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.